Braidwell portfolio · 2024-06-30
Disclosed long book
$1.93 billion
Long positions
75
Calls / puts
0 / 0
Top 5 concentration
25.1%
Longs with AI data
1 / 75
Average AI 1Y
+12.3%
13F filing comparison
Quarter-over-quarter changes
2024-03-31 to 2024-06-30
Newly reported
22
No longer reported
17
Increased
31
Reduced
13
Newly reported this quarter
Present now and absent from the immediately preceding comparable filing.
| Position | Kind | Shares | Value |
|---|---|---|---|
DEXCOM INC DEXCOM INC | LONG | 82,700,000 | $81.2 million |
EXACT SCIENCES CORP EXACT SCIENCES CORP | LONG | 1,141,678 | $48.2 million |
AVADEL PHARMACEUTICALS PLC AVADEL PHARMACEUTICALS PLC | LONG | 2,898,639 | $40.8 million |
KINIKSA PHARMACEUTICALS INTL KINIKSA PHARMACEUTICALS INTL | LONG | 2,058,303 | $38.4 million |
IMMUNOCORE HLDGS PLC IMMUNOCORE HLDGS PLC | LONG | 797,268 | $27.0 million |
AKERO THERAPEUTICS INC AKERO THERAPEUTICS INC | LONG | 1,084,400 | $25.4 million |
APELLIS PHARMACEUTICALS INC APELLIS PHARMACEUTICALS INC | LONG | 611,800 | $23.5 million |
ALPHATEC HLDGS INC ALPHATEC HLDGS INC | LONG | 2,194,900 | $22.9 million |
LEXICON PHARMACEUTICALS INC LEXICON PHARMACEUTICALS INC | LONG | 8,294,950 | $13.9 million |
ARVINAS INC ARVINAS INC | LONG | 517,230 | $13.8 million |
SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC | LONG | 81,900 | $12.9 million |
OCULAR THERAPEUTIX INC OCULAR THERAPEUTIX INC | LONG | 1,643,770 | $11.2 million |
THE BEAUTY HEALTH COMPANY THE BEAUTY HEALTH COMPANY | LONG | 5,120,685 | $9.8 million |
LIVANOVA PLC LIVANOVA PLC | LONG | 173,900 | $9.5 million |
DIANTHUS THERAPEUTICS INC DIANTHUS THERAPEUTICS INC | LONG | 366,851 | $9.5 million |
REPLIMUNE GROUP INC REPLIMUNE GROUP INC | LONG | 1,013,377 | $9.1 million |
CASTLE BIOSCIENCES INC CASTLE BIOSCIENCES INC | LONG | 416,100 | $9.1 million |
CELCUITY INC CELCUITY INC | LONG | 516,643 | $8.5 million |
LONGBOARD PHARMACEUTICALS IN LONGBOARD PHARMACEUTICALS IN | LONG | 205,926 | $5.6 million |
CONMED CORP CONMED CORP | LONG | 5,000,000 | $4.5 million |
DBV TECHNOLOGIES S A DBV TECHNOLOGIES S A | LONG | 2,442,504 | $2.0 million |
89BIO INC 89BIO INC | LONG | 164,227 | $1.3 million |
No longer reported this quarter
Present in the prior comparable filing and absent from this one.
| Position | Kind | Prior shares | Prior value |
|---|---|---|---|
ADAPTIVE BIOTECHNOLOGIES COR ADAPTIVE BIOTECHNOLOGIES COR · COM | LONG | 1,357,490 | $4.4 million |
ARCUTIS BIOTHERAPEUTICS INC ARCUTIS BIOTHERAPEUTICS INC · COM | LONG | 1,300,000 | $12.9 million |
AVADEL PHARMACEUTICALS PLC AVADEL PHARMACEUTICALS PLC · SPONSORED ADR | LONG | 2,668,549 | $45.1 million |
BIOCRYST PHARMACEUTICALS INC BIOCRYST PHARMACEUTICALS INC · COM | LONG | 3,379,577 | $17.2 million |
BIOMARIN PHARMACEUTICAL INC BIOMARIN PHARMACEUTICAL INC · COM | LONG | 218,896 | $19.1 million |
DBV TECHNOLOGIES S A DBV TECHNOLOGIES S A · SPONSORED ADR | LONG | 7,843,285 | $5.9 million |
DECIPHERA PHARMACEUTICALS IN DECIPHERA PHARMACEUTICALS IN · COM | LONG | 609,643 | $9.6 million |
EXACT SCIENCES CORP EXACT SCIENCES CORP · NOTE 0.375% 3/0 | LONG | 144,000,000 | $133.1 million |
INSMED INC INSMED INC · NOTE 1.750% 1/1 | LONG | 64,887,000 | $69.4 million |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · NOTE 0.750% 6/1 | LONG | 20,000,000 | $19.9 million |
ITEOS THERAPEUTICS INC ITEOS THERAPEUTICS INC · COM | LONG | 1,162,374 | $15.9 million |
KARYOPHARM THERAPEUTICS INC KARYOPHARM THERAPEUTICS INC · NOTE 3.000%10/1 | LONG | 65,976,000 | $35.8 million |
KINIKSA PHARMACEUTICALS LTD KINIKSA PHARMACEUTICALS LTD · COM CL A | LONG | 1,392,716 | $27.5 million |
MINERALYS THERAPEUTICS INC MINERALYS THERAPEUTICS INC · COM | LONG | 1,147,154 | $14.8 million |
OLEMA PHARMACEUTICALS INC OLEMA PHARMACEUTICALS INC · COM | LONG | 704,344 | $8.0 million |
STRUCTURE THERAPEUTICS INC STRUCTURE THERAPEUTICS INC · SPONSORED ADS | LONG | 435,823 | $18.7 million |
TOURMALINE BIO INC TOURMALINE BIO INC · COM | LONG | 906,820 | $20.8 million |
“No longer reported” means the position is absent from this comparable 13F filing. It does not prove the manager sold it: reporting thresholds, confidential treatment, corporate actions, or instrument changes can also explain the omission.
| Position | Kind | Shares | Value | Long weight | Quarter change | AI at filing · 1Y | AI now |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INC GUARDANT HEALTH INC · NOTE11/1 · 40131MAB5 | LONG | 268,252,000 | $208.1 million | — | UNCHANGED | — | 1Y — 5Y — |
BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · NOTE 2.500% 3/1 · 10806XAB8 | LONG | 140,838,000 | $143.0 million | — | INCREASED | — | 1Y — 5Y — |
NOVOCURE LTD NOVOCURE LTD · NOTE11/0 · 67011XAB9 | LONG | 140,834,000 | $129.8 million | — | INCREASED | — | 1Y — 5Y — |
NUVASIVE INC NUVASIVE INC · NOTE 0.375% 3/1 · 670704AJ4 | LONG | 114,206,000 | $110.1 million | — | UNCHANGED | — | 1Y — 5Y — |
NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC · COM · 64125C109 | LONG | 759,009 | $104.5 million | 5.4% | INCREASED | — | 1Y — 5Y — |
CG ONCOLOGY INC CG ONCOLOGY INC · COM · 156944100 | LONG | 3,309,507 | $104.5 million | 5.4% | INCREASED | — | 1Y — 5Y — |
XENON PHARMACEUTICALS INC XENON PHARMACEUTICALS INC · COM · 98420N105 | LONG | 2,560,573 | $99.8 million | 5.2% | INCREASED | — | 1Y — 5Y — |
APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC · COM · 03770N101 | LONG | 2,392,042 | $94.1 million | 4.9% | INCREASED | — | 1Y — 5Y — |
NEOGENOMICS INC NEOGENOMICS INC · NOTE 0.250% 1/1 · 64049MAB6 | LONG | 116,381,000 | $90.8 million | — | INCREASED | — | 1Y — 5Y — |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · NOTE 1.500% 6/1 · 46333XAH1 | LONG | 89,740,000 | $84.6 million | — | INCREASED | — | 1Y — 5Y — |
DEXCOM INC DEXCOM INC · NOTE 0.375% 5/1 · 252131AM9 | LONG | 82,700,000 | $81.2 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
GUARDANT HEALTH INC GUARDANT HEALTH INC · COM · 40131M109 | LONG | 2,807,968 | $81.1 million | 4.2% | INCREASED | — | 1Y — 5Y — |
INSULET CORP INSULET CORP · NOTE 0.375% 9/0 · 45784PAK7 | LONG | 68,000,000 | $74.4 million | — | INCREASED | — | 1Y — 5Y — |
LEGEND BIOTECH CORP LEGEND BIOTECH CORP · SPONSORED ADS · 52490G102 | LONG | 1,669,720 | $74.0 million | 3.8% | INCREASED | — | 1Y — 5Y — |
DEXCOM INC DEXCOM INC · NOTE 0.250%11/1 · 252131AK3 | LONG | 73,500,000 | $73.8 million | — | INCREASED | — | 1Y — 5Y — |
ARGENX SE ARGENX SE · SPONSORED ADR · 04016X101 | LONG | 166,924 | $71.8 million | 3.7% | REDUCED | — | 1Y — 5Y — |
ALIGN TECHNOLOGY INC ALIGN TECHNOLOGY INC · COM · 016255101 | LONG | 275,207 | $66.4 million | 3.4% | INCREASED | — | 1Y — 5Y — |
MARAVAI LIFESCIENCES HLDGS I MARAVAI LIFESCIENCES HLDGS I · COM CL A · 56600D107 | LONG | 9,024,037 | $64.6 million | 3.4% | INCREASED | — | 1Y — 5Y — |
VAXCYTE INC VAXCYTE INC · COM · 92243G108 | LONG | 808,303 | $61.0 million | 3.2% | REDUCED | — | 1Y — 5Y — |
SPYRE THERAPEUTICS INC SPYRE THERAPEUTICS INC · COM NEW · 00773J202 | LONG | 2,514,538 | $59.1 million | 3.1% | INCREASED | — | 1Y — 5Y — |
GLAUKOS CORP GLAUKOS CORP · COM · 377322102 | LONG | 496,576 | $58.8 million | 3.1% | INCREASED | — | 1Y — 5Y — |
VIKING THERAPEUTICS INC VIKING THERAPEUTICS INC · COM · 92686J106 | LONG | 1,106,905 | $58.7 million | 3.0% | INCREASED | — | 1Y — 5Y — |
IRHYTHM HOLDINGS INC IRHYTHM HOLDINGS INC · COM · 450056106 | LONG | 526,357 | $56.7 million | 2.9% | INCREASED | — | 1Y — 5Y — |
ALPHATEC HLDGS INC ALPHATEC HLDGS INC · NOTE 0.750% 8/0 · 02081GAB8 | LONG | 58,217,000 | $56.6 million | — | INCREASED | — | 1Y — 5Y — |
SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC · NOTE 1.250% 9/1 · 803607AD2 | LONG | 43,066,000 | $55.5 million | — | REDUCED | — | 1Y — 5Y — |
BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · NOTE 2.250% 2/0 · 10806XAD4 | LONG | 65,594,000 | $52.3 million | — | REDUCED | — | 1Y — 5Y — |
INSPIRE MED SYS INC INSPIRE MED SYS INC · COM · 457730109 | LONG | 379,443 | $50.8 million | 2.6% | INCREASED | — | 1Y — 5Y — |
TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC · NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $48.8 million | — | UNCHANGED | — | 1Y — 5Y — |
EXACT SCIENCES CORP EXACT SCIENCES CORP · COM · 30063P105 | LONG | 1,141,678 | $48.2 million | 2.5% | NEWLY REPORTED | — | 1Y — 5Y — |
KEROS THERAPEUTICS INC KEROS THERAPEUTICS INC · COM · 492327101 | LONG | 982,209 | $44.9 million | 2.3% | INCREASED | — | 1Y — 5Y — |
INTUITIVE SURGICAL INC INTUITIVE SURGICAL INC · COM NEW · 46120E602 | LONG | 100,500 | $44.7 million | 2.3% | UNCHANGED | — | 1Y — 5Y — |
DAY ONE BIOPHARMACEUTICALS I DAY ONE BIOPHARMACEUTICALS I · COM · 23954D109 | LONG | 3,035,904 | $41.8 million | 2.2% | INCREASED | — | 1Y — 5Y — |
REPLIGEN CORP REPLIGEN CORP · COM · 759916109 | LONG | 323,509 | $40.8 million | 2.1% | INCREASED | — | 1Y — 5Y — |
AVADEL PHARMACEUTICALS PLC AVADEL PHARMACEUTICALS PLC · COM SHS · G29687103 | LONG | 2,898,639 | $40.8 million | 2.1% | NEWLY REPORTED | — | 1Y — 5Y — |
TMO Thermo Fisher Scientific Inc. | LONG | 70,449 | $39.0 million | 2.0% | INCREASED | — | 1Y +12.3% 5Y +70.8% · 31 models |
KINIKSA PHARMACEUTICALS INTL KINIKSA PHARMACEUTICALS INTL · ORD SHS CL A · G52694109 | LONG | 2,058,303 | $38.4 million | 2.0% | NEWLY REPORTED | — | 1Y — 5Y — |
PENUMBRA INC PENUMBRA INC · COM · 70975L107 | LONG | 212,594 | $38.3 million | 2.0% | REDUCED | — | 1Y — 5Y — |
ORTHOPEDIATRICS CORP ORTHOPEDIATRICS CORP · COM · 68752L100 | LONG | 1,107,770 | $31.9 million | 1.7% | UNCHANGED | — | 1Y — 5Y — |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · COM CL A · 46333X108 | LONG | 4,438,232 | $28.9 million | 1.5% | INCREASED | — | 1Y — 5Y — |
TRANSMEDICS GROUP INC TRANSMEDICS GROUP INC · COM · 89377M109 | LONG | 189,960 | $28.6 million | 1.5% | REDUCED | — | 1Y — 5Y — |
PARAGON 28 INC PARAGON 28 INC · COM · 69913P105 | LONG | 4,150,109 | $28.4 million | 1.5% | INCREASED | — | 1Y — 5Y — |
IMMUNOCORE HLDGS PLC IMMUNOCORE HLDGS PLC · ADS · 45258D105 | LONG | 797,268 | $27.0 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
AKERO THERAPEUTICS INC AKERO THERAPEUTICS INC · COM · 00973Y108 | LONG | 1,084,400 | $25.4 million | 1.3% | NEWLY REPORTED | — | 1Y — 5Y — |
APELLIS PHARMACEUTICALS INC APELLIS PHARMACEUTICALS INC · COM · 03753U106 | LONG | 611,800 | $23.5 million | 1.2% | NEWLY REPORTED | — | 1Y — 5Y — |
ALPHATEC HLDGS INC ALPHATEC HLDGS INC · COM NEW · 02081G201 | LONG | 2,194,900 | $22.9 million | 1.2% | NEWLY REPORTED | — | 1Y — 5Y — |
LEXEO THERAPEUTICS INC LEXEO THERAPEUTICS INC · COM · 52886X107 | LONG | 1,382,481 | $22.2 million | 1.2% | INCREASED | — | 1Y — 5Y — |
KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC · COM · 501147102 | LONG | 107,179 | $19.7 million | 1.0% | REDUCED | — | 1Y — 5Y — |
RELAY THERAPEUTICS INC RELAY THERAPEUTICS INC · COM · 75943R102 | LONG | 3,006,799 | $19.6 million | 1.0% | REDUCED | — | 1Y — 5Y — |
NEVRO CORP NEVRO CORP · COM · 64157F103 | LONG | 1,698,768 | $14.3 million | 0.7% | REDUCED | — | 1Y — 5Y — |
LEXICON PHARMACEUTICALS INC LEXICON PHARMACEUTICALS INC · COM NEW · 528872302 | LONG | 8,294,950 | $13.9 million | 0.7% | NEWLY REPORTED | — | 1Y — 5Y — |
ARVINAS INC ARVINAS INC · COM · 04335A105 | LONG | 517,230 | $13.8 million | 0.7% | NEWLY REPORTED | — | 1Y — 5Y — |
SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC · COM · 803607100 | LONG | 81,900 | $12.9 million | 0.7% | NEWLY REPORTED | — | 1Y — 5Y — |
IOVANCE BIOTHERAPEUTICS INC IOVANCE BIOTHERAPEUTICS INC · COM · 462260100 | LONG | 1,466,610 | $11.8 million | 0.6% | INCREASED | — | 1Y — 5Y — |
OCULAR THERAPEUTIX INC OCULAR THERAPEUTIX INC · COM · 67576A100 | LONG | 1,643,770 | $11.2 million | 0.6% | NEWLY REPORTED | — | 1Y — 5Y — |
ALECTOR INC ALECTOR INC · COM · 014442107 | LONG | 2,380,704 | $10.8 million | 0.6% | UNCHANGED | — | 1Y — 5Y — |
HAEMONETICS CORP MASS HAEMONETICS CORP MASS · NOTE3/0 · 405024AB6 | LONG | 11,500,000 | $10.4 million | — | REDUCED | — | 1Y — 5Y — |
THE BEAUTY HEALTH COMPANY THE BEAUTY HEALTH COMPANY · COM CL A · 88331L108 | LONG | 5,120,685 | $9.8 million | 0.5% | NEWLY REPORTED | — | 1Y — 5Y — |
LIVANOVA PLC LIVANOVA PLC · SHS · G5509L101 | LONG | 173,900 | $9.5 million | 0.5% | NEWLY REPORTED | — | 1Y — 5Y — |
DIANTHUS THERAPEUTICS INC DIANTHUS THERAPEUTICS INC · COM · 252828108 | LONG | 366,851 | $9.5 million | 0.5% | NEWLY REPORTED | — | 1Y — 5Y — |
REPLIMUNE GROUP INC REPLIMUNE GROUP INC · COM · 76029N106 | LONG | 1,013,377 | $9.1 million | 0.5% | NEWLY REPORTED | — | 1Y — 5Y — |
CASTLE BIOSCIENCES INC CASTLE BIOSCIENCES INC · COM · 14843C105 | LONG | 416,100 | $9.1 million | 0.5% | NEWLY REPORTED | — | 1Y — 5Y — |
BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · COM · 10806X102 | LONG | 345,571 | $8.8 million | 0.5% | INCREASED | — | 1Y — 5Y — |
CELCUITY INC CELCUITY INC · COM · 15102K100 | LONG | 516,643 | $8.5 million | 0.4% | NEWLY REPORTED | — | 1Y — 5Y — |
4D MOLECULAR THERAPEUTICS IN 4D MOLECULAR THERAPEUTICS IN · COM · 35104E100 | LONG | 369,458 | $7.8 million | 0.4% | REDUCED | — | 1Y — 5Y — |
ELEVATION ONCOLOGY INC ELEVATION ONCOLOGY INC · COM · 28623U101 | LONG | 2,477,614 | $6.7 million | 0.3% | INCREASED | — | 1Y — 5Y — |
HARROW INC HARROW INC · COM · 415858109 | LONG | 297,188 | $6.2 million | 0.3% | INCREASED | — | 1Y — 5Y — |
LONGBOARD PHARMACEUTICALS IN LONGBOARD PHARMACEUTICALS IN · COM · 54300N103 | LONG | 205,926 | $5.6 million | 0.3% | NEWLY REPORTED | — | 1Y — 5Y — |
CUTERA INC CUTERA INC · NOTE 2.250% 6/0 · 232109AD0 | LONG | 25,240,000 | $5.0 million | — | UNCHANGED | — | 1Y — 5Y — |
CUTERA INC CUTERA INC · NOTE 4.000% 6/0 · 232109AG3 | LONG | 29,000,000 | $5.0 million | — | UNCHANGED | — | 1Y — 5Y — |
PULMONX CORP PULMONX CORP · COM · 745848101 | LONG | 752,541 | $4.8 million | 0.2% | UNCHANGED | — | 1Y — 5Y — |
CONMED CORP CONMED CORP · NOTE 2.250% 6/1 · 207410AH4 | LONG | 5,000,000 | $4.5 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
CULLINAN THERAPEUTICS INC CULLINAN THERAPEUTICS INC · COM · 230031106 | LONG | 176,173 | $3.1 million | 0.2% | REDUCED | — | 1Y — 5Y — |
OUTSET MED INC OUTSET MED INC · COM · 690145107 | LONG | 694,525 | $2.7 million | 0.1% | REDUCED | — | 1Y — 5Y — |
DBV TECHNOLOGIES S A DBV TECHNOLOGIES S A · SPONSORED ADR · 23306J200 | LONG | 2,442,504 | $2.0 million | 0.1% | NEWLY REPORTED | — | 1Y — 5Y — |
89BIO INC 89BIO INC · COM · 282559103 | LONG | 164,227 | $1.3 million | 0.1% | NEWLY REPORTED | — | 1Y — 5Y — |